Trial Details
RECRUITINGBasic Information
| Clinical ID | c1045 |
|---|---|
| Identifier | NCT05507203 |
| Trial Title | ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: ABX464|DRUG: Placebo |
Participant Information
| Sponsor | Abivax S.A. |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2022-10-10 |
|---|---|
| Primary Completion Date | 2025-03-25 |
| Completion Date | 2025-04-25 |